Business
Why the CSL (ASX:CSL) share price might be headed for more trouble
The CSL Ltd (ASX: CSL) share price has continued to trade sideways despite the S&P/ASX 200 Index (ASX: XJO) running around 6% higher year to date.
The ASX 200 is now within 2% of its pre-COVID high, but the CSL share price needs to add another 25% to be in a similar position. After what seemed like strong half-year results back in February, what’s next for the CSL share price?
CSL share price impacted by plasma collections
Plasma is an essential raw material for CSL Behring’s immunoglobulins, which generated US$4,256 million of the group’s US$5,739 million revenue in the first half of FY21.
The pandemic has adversely affected plasma collections, with December 2020 collection volumes representing ~80% of December 2019…
-
General18 hours agoUber driver says rideshare app tells workers to flout road rules as bill introduced
-
General14 hours agoPerson in potentially life-threatening condition after wall collapses in Brisbane’s West End
-
Noosa News10 hours agoPolice appealing for information about ‘suspicious’ Brisbane charity fire that killed 44-year-old man
-
Noosa News5 hours agoOne dead and crime scene declared after house fire in Redland Bay, south of Brisbane